Role of short haipin RNA targeting vascular endothelial growth factor C on biological characteristics of human breast cancer cell MCF-7

Chinese Journal of Pathology

Volumn 38, Issue 7, 2009, Pages 472-476

  Xie, Xiao Bin ^a   Long, Jie ^a   Yang, Fang ^a   Zhang, Ya Jie ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; RNA, small interfering; Tumor cells, cultured; Vascular endothelial growth factors

Indexed keywords

LIPOSOME; MESSENGER RNA; PUROMYCIN; RECOMBINANT VASCULOTROPIN; SHORT HAIRPIN RNA; VASCULOTROPIN C;

ARTICLE; BIOLOGICAL TRAIT; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL CLONE; CELL INVASION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NITROBLUE TETRAZOLIUM TEST; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENETIC VECTORS; HUMANS; NEOPLASM INVASIVENESS; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 70349093613     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2009.07.009     Document Type: Article

References (17)

1. Rubbia-Brandt L, Terris B, Giostra E, et al. Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clin Cancer Res,2004,10(20):6919- 6928. (Pubitemid 39383042)
2. Takabatake Y, Isaka Y, Mizui M, et al. Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther,2005,12(12):965-973.
3. Zhang XH, Huang DP, Guo GL, et al. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer,2008,8:4.
4. Matsumura S, Oue N, Mitani Y, et al. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer. Int J Cancer,2007,120(8): 1689-1695. (Pubitemid 46399355)
5. Calvani M, Trisciuoglio D, Bergamaschi C, et al. Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells. Cancer Res,2008,68(1):285-291.
6. Takizawa H, Kondo K, Fujino H, et al. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer. Br J Cancer,2006,95(1):75-79. (Pubitemid 43980557)
7. Hannon GJ, Conklin DS. RNA interference by short hairpin RNAs expressed in vertebrate cells. Methods Mol Biol,2004,257:255-266.
8. Troiani T, Lockerbie O, Morrow M, et al. Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases. Mol Cancer Ther,2006,5(7):1883-1889.
9. He XW, Liu T, Chen YX, et al. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo. Cancer Gene Ther,2008,15(3):193-202. (Pubitemid 351240670)
10. Ueda M, Hung YC, Terai Y, et al. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Clin Cancer Res,2005,11(9):3225-3232. (Pubitemid 40627869)
11. Ricca A, Biroccio A, Del Bufalo D, et al. bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int J Cancer,2000,86(2):188-196.
12. Dias S, Choy M, Alitalo K, et al. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood,2002,99(6):2179-2184.